We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Mortality After Perioperative β-Blocker Use in Noncardiac Surgery

Ishak Mansi, MD1; Eric M. Mortensen, MD, MSc1
[+] Author Affiliations
1North Texas Veterans Health Care System, Dallas
JAMA. 2013;310(6):645-646. doi:10.1001/jama.2013.8519.
Text Size: A A A
Published online


To the Editor The large propensity score–matched study by Dr London and colleagues1 concluded that perioperative use of β-blockers was associated with lower 30-day mortality in patients undergoing noncardiac surgery. Two major flaws limit the study’s application as well as the validity of its conclusion.

The first problem is their choice of conditions included in the propensity score matching of patients who were either exposed or not exposed to β-blockers. These conditions included angina within 30 days preoperatively, myocardial infarction 6 months preoperatively, previous coronary intervention procedure, and congestive heart failure 30 days preoperatively (eTable 5 of the article). Because use of β-blockers is strictly indicated in patients who have any of these conditions, the patients who were exposed to β-blockers must be different from those who were not given β-blockers; unexposed patients might have had a contraindication to β-blockers, have been too frail to tolerate them, or were treated at a lower level of care.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Related Collections